RT Journal
A1 Weed DL
T1 HIgher standards for epidemiologic studies—replication prior to publication?
JF JAMA
JO JAMA
YR 1999
FD September 8
VO 282
IS 10
SP 937
OP 938
DO 10.1001/jama.282.10.937
UL http://dx.doi.org/10.1001/jama.282.10.937
AB 
To the Editor: In his commentary on epidemiologic
studies and meta-analysis in drug development and surveillance, Dr Temple1 suggests that medical journals impose 3 higher
standards on epidemiologic studies. Two of these should invoke little concern.
Who is not in favor of any scientist doing a better job describing methods
and their limitations? However, Temple's third suggestion—that epidemiologic
studies with relative risks of 2.0 or less not be published until replicated
in a different environment—is alarming.